Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Poland Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20062
20071
20086
20092
20102
20111
20122
20134
20142
20152
20173
20183
20194
20201
20218
20224
20235
20245
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated13
Recruiting8
Active, not recruiting4
Enrolling by invitation2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion17
United Therapeutics10
Bayer6
Merck Sharp & Dohme LLC4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Novartis Pharmaceuticals3
AOP Orphan Pharmaceuticals AG2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
Aerovate Therapeutics2
AllRock Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension62
Hypertension, Pulmonary21
Hypertension3
Cardiovascular Diseases2
Connective Tissue Diseases2
Eisenmenger Complex2
Familial Primary Pulmonary Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 26 to 50 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.